With Robust Molecular Tumor Registry "MrT," The Stars Align Wrestling with “next generation sequencing," this Mr. T is helping Duke oncologists utilize a Molecular Tumor Board to deliver patient centered precision cancer medicine. June 24, 2019 DCI Research Employee Resources
